CD274 and glioblastoma: We have previously demonstrated the effectiveness of functionalized lipid nanoparticles (LNPs) for therapeutic delivery to GBM-associated TAMCs in vivo by targeting the programmed death-ligand 1 (PD-L1), which is overexpressed in these cells, particularly when combined with RT22.